The CarDS Lab at Yale utilizes AI-driven technology and computational phenotyping to enhance cardiovascular diagnostics through tools like AI-ECG and AI-Echo, enabling precise identification of cardiovascular diseases from various imaging formats. Their solutions address the inefficiencies in cardiovascular care by providing real-time risk stratification and diagnosis, ultimately improving patient outcomes and safety.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cardiovascular diagnostics often suffer from inefficiencies, requiring specialized equipment and expertise, which can lead to delays in diagnosis and treatment. Analyzing cardiovascular data from various imaging formats is complex and time-consuming, hindering timely risk stratification and intervention.
Solution
The CarDS Lab develops AI-driven tools, including AI-ECG and AI-Echo, to enhance cardiovascular diagnostics and provide real-time risk stratification. Their solutions leverage computational phenotyping and machine learning to analyze cardiovascular data from various imaging formats, enabling precise identification of cardiovascular diseases and disorders. By applying advanced data science to clinical trials and electronic health records, they aim to improve patient outcomes and safety through personalized assessment and care quality inference. The CarDSPlus platform extends diagnostic capabilities to wearable devices, allowing for continuous monitoring and early detection of structural heart disorders.
Target Audience
The primary audience includes cardiologists, healthcare providers, and clinical researchers focused on improving cardiovascular diagnostics, risk stratification, and patient outcomes.
Features
- AI-ECG: Analyzes electrocardiogram (ECG) images, regardless of format, to diagnose cardiovascular diseases.
- AI-Echo: Combines AI models with echocardiography images for advanced echocardiographic interpretation.
- Precision Toolkit: Personalizes the assessment of randomized clinical trials using advanced data science and machine learning.
- CarDSPlus ECG Platform: Connects with wearable devices like Apple Watch and Fitbit for real-time ECG analysis and detection of structural heart disorders.
- Digital twin technology for cardiovascular care using generative AI.
- Tools for precision clinical trial inference and electronic care quality inference.